Patent · US Active

Ultrafiltration unit for continuous buffer or medium exchange from a protein solution

US10421042B2 · kind B2 · utility

0Cited by

5References

9Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Peter SCHWAN · Leverkusen, DE
Lutz-Peter Lenz · Solingen, DE
Kerstin Baumarth · Wuppertal, DE
Martin LOBEDANN · Cologne, DE

Key dates

Filing date	Feb 13, 2015
Grant date	Sep 24, 2019
Priority date	—
Expiry date	Jan 21, 2036

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB01D2317/04
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

The invention relates to an ultrafiltration unit for continuous buffer or medium exchange, a method for continuous buffer or medium exchange in the ultrafiltration unit, and a plant in particular for (semi)continuous production of biopharmaceutical and biological macromolecular products in particular, such as proteins, e.g. monoclonal antibodies and vaccines, comprising the ultrafiltration unit according to the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.